Company/Division name | STA Pharmaceutical |
Parent company | Wuxi AppTech |
Type of work | Manufacturing |
Reshoring category: | Foreign Direct Investment |
Total number of jobs (added or to be added): | 479 |
Year reshoring announced: | 2022 |
Year reshoring implemented or to be implemented: | 2024 |
Domestically, the work will be done: | In-house |
Capital investment ($): | 510 |
Country(ies) from which reshored: | China |
City reshored to: | Middletown |
State(s) reshored to: | DE |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | pharmaceuticals |
What domestic positive factors made reshoring more attractive? | Government Incentives |
Government Incentive dollar amount: | 19,000,000 |